To evaluate the impact of the interaction of QRS duration and morphology on left ventricular (LV) reverse remodelling and LV functional improvement in heart failure (HF) patients treated with cardiac resynchronization therapy (CRT 
Introduction
Cardiac resynchronization therapy (CRT) is an established treatment for heart failure (HF) patients who remain symptomatic despite optimal medical therapy [New York Heart Association (NYHA) functional class II-III and ambulatory class IV], with a wide QRS complex (≥120 ms) and reduced left ventricular ejection fraction (LVEF ≤35%). 1 The benefits of CRT may differ, based on QRS complex duration and morphology. Recent registries, meta-analyses and substudies of randomized controlled trials have shown that patients with left bundle branch block (LBBB) morphology and QRS duration ≥150 ms appear to benefit most from CRT in terms of improvement of clinical symptoms and survival, 2 -4 whereas in patients with non-LBBB morphology the benefit may be less, particularly when the QRS duration is <130 ms. 5 However, little is known about the influence of QRS duration and morphol-ogy on the extent of LV reverse remodelling and improvement in LVEF. Accordingly, the present study evaluated the relation between baseline QRS duration and morphology, and LV reverse remodelling and LV systolic function improvement after CRT in a large population of HF patients (including NYHA class I-IV).
Methods

Patient population
This retrospective, single-centre study, included symptomatic HF patients that despite receiving maximum tolerated doses of optimal medical therapy subsequently underwent CRT implantation according to contemporary guidelines. 1 Demographic, clinical, electrocardiographic (ECG), and echocardiographic characteristics were analysed. The QRS duration and morphology were dichotomized into groups <150 ms vs. ≥150 ms and LBBB vs. non-LBBB, respectively. Echocardiographic measurements were performed at baseline (before CRT implantation) and at 6 months' follow-up, according to current guidelines on LV chamber quantification. 6 Left ventricular end-diastolic volume (LVEDV), LV end-systolic volume (LVESV) and LVEF were compared at baseline and 6 months' follow-up between patients with and without LBBB, as well as between patients with QRS duration ≥150 ms and <150 ms.
The Dutch Central Committee on Human-related Research (CCMO) allows the use of anonymous data without prior approval of an institutional review board provided that the data are acquired for routine patient care. All data used for the present study were acquired for clinical purposes and handled anonymously.
Analysis of QRS morphology and duration
The QRS duration was determined by automated, digital algorithms from a 12-lead surface ECG. Calibration of the ECG was set at 0.1 mV/mm and the paper speed was 25 mm/s. Previously-defined criteria were employed to define a LBBB, with the intrinsic complex being evaluated in the case of pre-existing pacing. 7 
Echocardiographic data acquisition and analysis
Before CRT implantation and at 6 months' follow-up, transthoracic echocardiography was performed in all patients in the left lateral decubitus position using a commercially available echocardiographic system (E9 or VIVID 7; General Electric Vingmed Ultrasound, Milwaukee, WI, USA). Images were obtained using 3.5 MHz or M5S transducers, adjusting depth and gain settings. M-mode, two-dimensional and Doppler data, triggered to the ECG, were acquired and digitally stored for off-line analysis (EchoPac 113; General Electric Vingmed Ultrasound). The LVESV, LVEDV and LVEF were measured from the apical two-and four-chamber views, using the modified Simpson's biplane method.
Implantation of cardiac resynchronization therapy device
The right atrial and ventricular leads were positioned conventionally through a subclavian or cephalic vein. a coronary sinus venogram was obtained using a balloon catheter and the LV pacing lead was inserted in the coronary sinus with the help of an 8 Fr guiding catheter and positioned, preferably, in a (postero-) lateral vein. All leads were connected to a dual-chamber biventricular CRT device. The majority of the patients (94%) received a CRT device with defibrillator function (ICD) and 6% received a CRT device without defibrillator capability. Evaluation of the device function was combined with the regular controls at the HF outpatient clinic. The atrioventricular and interventricular delays were set empirically at 120-140 ms and 0 ms, respectively, and CRT optimization was performed at follow-up at the discretion of the treating physician.
Statistical analysis
Continuous variables are presented as mean and standard deviation (SD) when normally distributed. Dichotomous data are presented as numbers and percentages. Student t-tests were used to compare continuous variables, and chi-square tests were used to compare dichotomous data. Changes in LVESV, LVEDV and LVEF at 6 months' follow-up were compared within and between groups using linear, mixed models corrected for gender and HF aetiology. All analyses were performed with SPSS for Windows, version 23.0 (SPSS, Armonk, NY, USA). All statistical tests were two-sided. A P-value <0.05 was considered statistically significant.
Results
A total of 1467 patients (mean age 65 ± 10 years, 77% male) were included in the analysis ( Table 1) . Ischaemic cardiomyopathy was diagnosed in 59% of patients. A LBBB was present in 55% of patients and the mean QRS duration was 156 ± 33 ms, with 60% of patients having a QRS duration ≥150 ms. Compared with patients with LBBB QRS morphology, patients with non-LBBB QRS morphology were more frequently male, more frequently had ischaemic cardiomyopathy and atrial fibrillation, and showed significantly better LVEF and smaller LV volumes. Compared with patients with QRS duration ≥150 ms, patients with QRS duration < 150 ms were significantly younger, more frequently had ischaemic cardiomyopathy, less frequently had chronic kidney disease, showed significantly better LVEF and smaller LV volumes, and were more frequently treated with beta-blockers.
Influence of QRS duration and morphology on left ventricular reverse remodelling and improvement in left ventricular ejection fraction
The mean changes in LV volumes and LVEF, according to QRS morphology and duration, are summarized in Table 2 . Patients with LBBB configuration exhibited greater LV reverse remodelling, greater decrease in LVEDV and improvement of LVEF than patients with non-LBBB QRS morphology. Similarly, patients with QRS duration ≥150 ms demonstrated greater LV reverse remodelling, greater reduction in LVEDV and improvement of LVEF compared with those with QRS duration <150 ms. Figure 1 illustrates the influence of QRS duration on the reduction of LVEDV after CRT in patients with LBBB vs. patients with non-LBBB. Regardless of QRS morphology, the reduction in LVEDV was more pronounced with increasing width of the QRS, particularly with QRS duration ≥150 ms (inflection point). Beyond a QRS duration >190 ms, a further decrease in LVEDV was not observed for patients with LBBB morphology whereas patients with a non-LBBB QRS configuration showed a progressive reduction in LVEDV. reduction in LVESV was observed with increasing duration of the QRS, particularly at ≥140 ms for both LBBB and non-LBBB patients. Figure 3 illustrates the influence of QRS duration as a continuous variable (dichotomized into patients with LBBB vs. non-LBBB) on changes in LVEF. The LVEF increased particularly in patients with QRS duration ≥150 ms and LBBB morphology, and appeared to reach a plateau beyond 170 ms. Improvement in LVEF in patients with non-LBBB morphology was similar across the various QRS durations. 
Discussion
The main findings of the present study are the greater benefit of CRT [in terms of LV reverse remodelling (defined as reduction in LVESV) and improvement in LVEF] in HF patients with LBBB and a QRS duration ≥150 ms, compared with patients with non-LBBB QRS morphology or shorter QRS duration.
Influence of QRS morphology and duration on efficacy of cardiac resynchronization therapy
Several studies have demonstrated the influence of QRS morphology and duration on the outcome of HF patients treated with CRT. 8 -11 In a large, retrospective cohort study, which included 24 169 patients treated with CRT, Peterson et al. 4 showed that patients with LBBB morphology and a QRS duration ≥150 ms presented lower rates of all-cause mortality (20.9% at 3 years) compared with patients with LBBB and QRS <150 ms (26.5% at 3 years) or with non-LBBB morphology (30.7% for QRS ≥150 ms and 32.3% for QRS <150 ms). These findings were also observed in a meta-analysis of five randomized trials including 5813 CRT patients: QRS duration ≥150 ms was significantly . associated with a reduction in the risk of the composite clinical endpoint [risk ratio (RR) 0.60, 95% confidence interval (CI), 0.53-0.67; P < 0.001)] whereas a QRS duration between 120 and 149 was not (RR 0.95, 95% CI 0.82-1.10; P = 0.49). 12 In the Resynchronization/defibrillation for Ambulatory Heart Failure Trial (RAFT), 2 all-cause mortality and hospitalization for HF was reduced in patients with LBBB morphology, but not in those with non-LBBB morphology. In a meta-analysis of four randomized controlled trials reported by Sipahi et al. (including 5356 patients), 13 composite clinical events (all-cause mortality and HF hospitalization) were reduced in patients with LBBB (RR 0.64, 95% CI 0.52-0.77; P = 0.00001), but not in patients with a non-LBBB morphology (RR 0.97, 95% CI 0.82-1.15; P = 0.75).
Importantly, the prognosis of patients with CRT is also influenced by the response to CRT at mid-term follow-up, defined as LV reverse remodeling.
14 -16 In a study that included 679 patients treated with CRT, LV reverse remodelling (reduction of ≥15% in LVESV) at 6 months' follow-up was associated with better prognosis independently of improvement in clinical status.
14 How QRS duration and morphology affect the extent of LV reverse remodelling and the degree of improvement in LV systolic function after CRT has not been extensively studied, especially in patients with more advanced stages of HF (NYHA class III and IV).
QRS morphology and duration vs. left ventricular reverse remodelling and improvement in left ventricular ejection fraction after cardiac resynchronization therapy
The effects of CRT on LV volumes and LVEF according to the QRS duration and morphology have been studied in few randomized trials that have included only patients with HF and NYHA class I and II symptoms. 10, 17 In the Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy (MADIT-CRT) trial, randomizing 1820 patients (70% with LBBB morphology) with mild HF (NYHA classes I and II) to CRT-D vs. ICD alone, patients with LBBB morphology had a greater decrease in LVEDV compared with those with non-LBBB (56.7 ± 34.1 mL vs. 41.0 ± 28.13 mL, respectively; P < 0.001).
10
Patients with LBBB also experienced a greater decrease in LVESV than patients with non-LBBB (62.1 ± 31.5 mL vs. 45.7 ± 28.13 mL, respectively; P < 0.001).
10 Lastly, LVEF improved by 11.9 ± 5.1% in the LBBB group compared with 8.8 ± 4.9% in the non-LBBB group (P < 0.001).
10 Similarly, in the REsynchronization reVErses Remodelling in Systolic left vEntricular dysfunction (REVERSE) trial, 610 patients with mild HF (NYHA classes I and II; 60% with LBBB morphology) randomized to CRT-ON vs. CRT-OFF, patients with LBBB experienced a 25.3 mL/m 2 mean reduction in LVESV index (P < 0.0001), whereas non-LBBB patients had smaller reductions in LVESV (6.7 mL/m 2 ; P = 0.18). 17 Moreover, baseline QRS duration was also a strong predictor of the change in LVESV index in the REVERSE trial. When patients were divided into quartiles according to baseline QRS duration, a progressively greater decrease in LVESV index was observed at 12 months' follow-up for longer QRS durations.
17
Our results are consistent with the MADIT-CRT and REVERSE trials, 10, 17 with LBBB and increasing QRS duration (especially ≥150 ms) constituting the group of HF patients who benefit most from CRT in terms of LV reverse remodelling and improvement in LVEF. In addition, similar to the REVERSE substudy, 17 the differences in LV reverse remodelling and improvement in LVEF remained significant after correcting for known confounders such as ischaemic HF. More importantly, the present study expands the results of these randomized controlled trials by including a large number of patients with severe HF (NYHA classes III and IV). This is highly relevant, as the majority of patients in previous randomized controlled trials and large registries had NYHA class III HF symptoms.
4,18 -20 However, the association between QRS morphology and duration and changes in LV volumes and LVEF after CRT in that group of patients has not been described previously. In addition, although the efficacy of CRT in NYHA functional class IV has been debated, our results show that this group of patients may also show significant reduction in LV volumes and improvement in LVEF, thus supporting CRT implantation in this group of patients, as indicated in current guidelines. The results of the present study also support these recommendations as, for the first time, they demonstrate that the greatest benefit from CRT (in terms of LV reverse remodelling and LVEF improvement) was observed in a large population of NYHA class I-IV HF patients with LBBB morphology and a QRS duration ≥150 ms.
Study limitations
This study was limited by its design-a retrospective, single-centre study-but an advantage is that it reflects experience from a large, real-word, referral centre. In this population, the number of patients receiving beta-blockers was still fairly low, although it was higher compared with many landmark trials, which established the utility of CRT. 18 -20,24-27 This probably reflects that in daily practice, a significant percentage of severe HF patients do not tolerate beta-blockers. It is also known that other factors, such as the extent of scar tissue in the left ventricle and the LV lead position may influence the response to CRT. These factors were not systematically available in the current population.
Conclusions
Left ventricular reverse remodelling and functional improvement are greater among HF patients with LBBB QRS morphology and increasing QRS duration (especially ≥150 ms) who received CRT. These findings are supportive of contemporary guidelines for CRT placement.
